ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011

Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson.

January 12, 2007

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept

May 22, 1981

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999